Evidence map›Paper›PMID 37949972›Full record

ArticleScientific reports2023

Activation-induced cytidine deaminase an antibody diversification enzyme interacts with chromatin modifier UBN1 in B-cells.

Ankit Jaiswal, Rajarshi Roy, Anubhav Tamrakar, Amit Kumar Singh, Parimal Kar, Prashant Kodgire

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ankit JaiswalDepartment of Biosciences and Biomedical Engineering, Indian Institute of Technology, Indore, Madhya Pradesh, 453 552, India.
Rajarshi RoyDepartment of Biosciences and Biomedical Engineering, Indian Institute of Technology, Indore, Madhya Pradesh, 453 552, India.
Anubhav TamrakarDepartment of Biosciences and Biomedical Engineering, Indian Institute of Technology, Indore, Madhya Pradesh, 453 552, India.
Amit Kumar SinghDepartment of Biosciences and Biomedical Engineering, Indian Institute of Technology, Indore, Madhya Pradesh, 453 552, India.
Parimal KarDepartment of Biosciences and Biomedical Engineering, Indian Institute of Technology, Indore, Madhya Pradesh, 453 552, India.
Prashant KodgireDepartment of Biosciences and Biomedical Engineering, Indian Institute of Technology, Indore, Madhya Pradesh, 453 552, India. pkodgire@iiti.ac.in.
Indian Institute of Technology Indore · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Activation-induced cytidine deaminase (AID) is the key mediator of antibody diversification in activated B-cells by the process of somatic hypermutation (SHM) and class switch recombination (CSR). Targeting AID to the Ig genes requires transcription (initiation and elongation), enhancers, and its interaction with numerous factors. Furthermore, the HIRA chaperon complex, a regulator of chromatin architecture, is indispensable for SHM. The HIRA chaperon complex consists of UBN1, ASF1a, HIRA, and CABIN1 that deposit H3.3 onto the DNA, the SHM hallmark. We explored whether UBN1 interacts with AID using computational and in-vitro experiments. Interestingly, our in-silico studies, such as molecular docking and molecular dynamics simulation results, predict that AID interacts with UBN1. Subsequently, co-immunoprecipitation and pull-down experiments established interactions between UBN1 and AID inside B-cells. Additionally, a double immunofluorescence assay confirmed that AID and UBN1 were co-localized in the human and chicken B-cell lines. Moreover, proximity ligation assay studies validated that AID interacts with UBN1. Ours is the first report on the interaction of genome mutator enzyme AID with UBN1. Nevertheless, the fate of interaction between UBN1 and AID is yet to be explored in the context of SHM or CSR.

Indexed as

ChromatinTranscription FactorsAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseHumansImmunoglobulin Class SwitchingImmunoglobulinsMolecular ChaperonesMolecular Docking SimulationNuclear ProteinsSomatic Hypermutation, ImmunoglobulinAICDA (Activation-Induced Cytidine Deaminase)ChromatinCytidine DeaminaseImmunoglobulinsMolecular ChaperonesNuclear ProteinsTranscription FactorsUBN1 protein, human

Identifiers

PMID37949972
PMCPMC10638239
OpenAlexW4388573268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.